Omada Health (OMDA) — Analyst outlook / Analyst consensus target is. Based on 8 analyst ratings, the consensus is bullish — 8 Buy.
The consensus price target is $24.80 (low: $17.00, high: $32.00), representing an upside of 99% from the current price $12.46.
Analysts estimate Earnings Per Share (EPS) of $-2.81 and revenue of $0.21B for the next fiscal year.
Earnings Per Share (EPS) track record: 2025: actual $-0.22 vs est $-0.03 (missed -711.6%). Analyst accuracy: 12%.
OMDA Stock — 12-Month Price Forecast
$24.80
▲ +99.04% Upside
Average Price Target
Based on 8 Wall Street analysts offering 12-month price targets for Omada Health, the average price target is $24.80, with a high forecast of $32.00, and a low forecast of $17.00.
The average price target represents a +99.04% change from the last price of $12.46.
Highest Price Target
$32.00
Average Price Target
$24.80
Lowest Price Target
$17.00
OMDA Analyst Ratings
Buy
Based on 8 analysts giving stock ratings to Omada Health in the past 3 months
EPS Estimates — OMDA
12%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.00
vs Est –$2.81
▲ 0.0% off
2025
Actual –$0.22
vs Est –$0.03
▼ 87.7% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — OMDA
87%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.170B
vs Est $0.210B
▼ 23.6% off
2025
Actual $0.260B
vs Est $0.254B
▲ 2.4% off
Revenue Trend
Strong revenue growth over the period shown. Analysts forecast revenue contraction ahead.
